Posted by admin on Aug 19th, 2022 
Commerce Bank decreased its position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) by 8.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,332 shares of the company’s stock after selling 390 shares during the period. Commerce Bank’s holdings in Bath & Body Works were worth $207,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Prospera Financial Services Inc acquired a new position in Bath & Body Works during the 1st quarter worth $25,000. Acadian Asset Management LLC acquired a new position in Bath & Body Works during the 4th quarter worth $30,000. CVA Family Office LLC grew its holdings in Bath & Body Works by 153.4% during the 1st quarter. CVA Family Office LLC now owns 735 shares of the company’s stock worth $35,000 after acquiring an additional 445 shares in the last quarter. Alpha Paradigm Partners LLC acquired a new position in Bath & Body Works during the 4th quarter worth $40,000. Finally, CWM LLC acquired a new position in Bath & Body Works during the 4th quarter worth $42,000. Hedge funds and other institutional investors own 97.11% of the company’s stock.
BBWI stock opened at $40.26 on Friday. Bath & Body Works, Inc. has a 52 week low of $25.75 and a 52 week high of $82.00. The company has a market capitalization of $9.21 billion, a price-to-earnings ratio of 10.68, a price-to-earnings-growth ratio of 3.92 and a beta of 1.82. The firm’s 50-day moving average is $32.73 and its two-hundred day moving average is $43.57.
Bath & Body Works (NYSE:BBWI – Get Rating) last released its quarterly earnings results on Wednesday, August 17th. The company reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. Bath & Body Works had a net margin of 12.31% and a negative return on equity of 57.40%. The company had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.61 billion. During the same period in the previous year, the firm earned $1.34 EPS. Bath & Body Works’s revenue was down 5.1% on a year-over-year basis. On average, equities research analysts predict that Bath & Body Works, Inc. will post 2.64 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, September 2nd. Shareholders of record on Friday, August 19th will be given a dividend of $0.20 per share. The ex-dividend date is Thursday, August 18th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.99%. Bath & Body Works’s dividend payout ratio (DPR) is 21.22%.
In related news, insider Thomas E. Mazurek sold 16,338 shares of the business’s stock in a transaction that occurred on Friday, May 27th. The shares were sold at an average price of $42.25, for a total value of $690,280.50. Following the sale, the insider now directly owns 11,225 shares in the company, valued at approximately $474,256.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.37% of the stock is owned by insiders.
BBWI has been the subject of several recent analyst reports. Robert W. Baird raised their price objective on shares of Bath & Body Works from $40.00 to $48.00 and gave the stock an “outperform” rating in a report on Thursday. BMO Capital Markets lifted their price target on shares of Bath & Body Works from $45.00 to $48.00 and gave the company an “outperform” rating in a report on Thursday. Raymond James began coverage on shares of Bath & Body Works in a report on Tuesday, July 12th. They issued a “strong-buy” rating and a $45.00 price target for the company. B. Riley lifted their price target on shares of Bath & Body Works from $44.00 to $48.00 in a report on Tuesday. Finally, JPMorgan Chase & Co. lowered shares of Bath & Body Works from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $63.00 to $30.00 in a report on Wednesday, June 29th. Four equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $50.62.
(Get Rating)
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Get Rating).
Receive News & Ratings for Bath & Body Works Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bath & Body Works and related companies with MarketBeat.com’s FREE daily email newsletter.
Texas Permanent School Fund Decreases Stock Position in American Axle & Manufacturing Holdings, Inc. (NYSE:AXL)
Commerce Bank Sells 773 Shares of Pentair plc (NYSE:PNR)
